D-0249-2018 Class III Terminated

Recalled by Taro Pharmaceuticals U.S.A., Inc. — Hawthorne, NY

FDA drug recall D-0249-2018 was initiated by Taro Pharmaceuticals U.S.A., Inc. on Dec 21, 2017 and is designated Class III. Reason for recall: Failed Content Uniformity Specifications The recall status is terminated (terminated Sep 21, 2020). Affected quantity: 27,792 tubes.

Recall details

Product Type
Drugs
Report Date
Feb 7, 2018
Initiation Date
Dec 21, 2017
Termination Date
Sep 21, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
27,792 tubes

Product description

Clobetasol Propionate Cream USP, 0.05% 60 g tube, Rx only Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761 Dist. by : Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532 UPC 351672125837 NDC 51672-1258-3

Reason for recall

Failed Content Uniformity Specifications

Distribution pattern

Nationwide

Code information

Lot 311235, exp Sept 2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0249-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0249-2018. Report a data issue: hello@regdatalab.com.